Pregnenolone (LC-MS/MS) Test
Pregnenolone is the master steroid precursor, the first product of steroidogenesis from cholesterol and the common upstream substrate for all steroid hormones. Measured by LC-MS/MS — the reliable reference method, unlike immunoassay — it is used mainly to characterise steroidogenic enzyme defects and adrenal steroidogenesis, typically within a steroid-precursor panel rather than as a standalone…
1
Biomarkers
Blood (serum)
Sample
3–6 business days
Turnaround
No — fasting is not specifically required, though an early-morning sample is preferred because of the diurnal rhythm of adrenal steroidogenesis
Fasting
What is the Pregnenolone test?
The Pregnenolone (LC-MS/MS) Test measures serum pregnenolone — the master steroid precursor and the first committed product of steroidogenesis from cholesterol, upstream of all steroid hormones. It is ordered to characterise the steroidogenic pathway, most usefully to help localise enzymatic blocks in congenital adrenal hyperplasia and related disorders, and as an upstream reference point when downstream steroids are abnormal. Mass spectrometry is used because immunoassay pregnenolone cross-reacts with related steroids and is unreliable, whereas LC-MS/MS is specific across the low concentration range. Within steroid and adrenal assessment, pregnenolone is a specialist, generally second-line marker rather than a standalone diagnostic. More targeted tests are first-line for the common questions — 17-hydroxyprogesterone for 21-hydroxylase congenital adrenal hyperplasia, cortisol with ACTH for adrenal insufficiency, and DHEA-sulfate for adrenal androgen output — and pregnenolone is most informative as part of a steroid-precursor panel that maps the pathway, where an early-precursor value helps interpret the pattern of downstream steroids. It is also frequently ordered in functional 'adrenal' assessments, but that interpretation is not well established, and pregnenolone alone rarely resolves a clinical question. Because of its low concentration and diurnal variability, an early-morning sample and a mass-spectrometry method are preferred, and results are read alongside the wider steroid profile.
What does the Pregnenolone test measure?
Pregnenolone is the first product of steroidogenesis, formed from cholesterol by the side-chain cleavage enzyme (CYP11A1) in mitochondria — the rate-limiting committed step of steroid synthesis. It is the common upstream precursor for all steroid hormones, feeding the progestogen, glucocorticoid, mineralocorticoid, androgen, and oestrogen pathways, and is produced in the adrenal cortex, gonads, and brain (as a neurosteroid). It circulates at low concentrations with a short half-life.
Pregnenolone is measured mainly to characterise steroidogenesis — most usefully to help localise enzymatic blocks in congenital adrenal hyperplasia and related steroidogenic disorders, and as an upstream reference point when downstream steroids are abnormal. Measured by LC-MS/MS, it avoids the cross-reactivity that makes immunoassay pregnenolone unreliable. It is also used in some functional and integrative 'adrenal precursor' assessments, an application whose interpretation is not well established.
Why is the Pregnenolone test ordered?
- Investigation of suspected steroidogenic enzyme defects or congenital adrenal hyperplasia, as part of a steroid-precursor panel to help localise the pathway block
- Assessment of adrenal steroidogenesis where an early-pathway precursor adds information alongside 17-hydroxyprogesterone, DHEA-sulfate, cortisol, and ACTH
- Characterisation of unexplained abnormalities in downstream steroids, where an upstream precursor clarifies the pattern
- Situations where a previously reported immunoassay pregnenolone is unreliable and a mass-spectrometry measurement is required
- Monitoring in patients taking pregnenolone supplements, where documented supplementation and timing relative to collection are essential to interpretation
- Specialist endocrine workups of steroidogenesis disorders or ambiguous steroid profiles, in conjunction with genetic and other biochemical testing
- Functional and integrative assessment of steroid-hormone precursors, interpreted with explicit awareness that this application is not well established
Sample collection and turnaround
Sample type
Blood (serum)
Fasting required
No — fasting is not specifically required, though an early-morning sample is preferred because of the diurnal rhythm of adrenal steroidogenesis
Collection method
Venipuncture at patient service centre
Turnaround
3–6 business days
Collection notes
Collect in the early morning where the diurnal rhythm is relevant. Document pregnenolone, DHEA, or other steroid-precursor supplementation, glucocorticoid and hormone therapy, and timing relative to dosing; note menstrual cycle phase in women where relevant. Use the same method for serial monitoring.
Specimen requirements
Minimum 0.5 mL serum. Separate serum from cells per Access Medical Laboratories protocol. Specimen stable refrigerated; follow Access Medical Laboratories transport guidelines.
What can affect Pregnenolone results?
Over-the-counter pregnenolone and related precursor supplements raise measured levels and reflect recent intake rather than endogenous production, so supplementation and timing relative to collection must be documented.
Exogenous glucocorticoids suppress ACTH and adrenal steroidogenesis, lowering pregnenolone independent of a primary steroidogenic disorder, so corticosteroid use should be documented.
Adrenal steroidogenesis follows an ACTH-driven diurnal rhythm and rises with acute stress and illness, so an early-morning sample on a representative day is preferred and single values are interpreted with this in mind.
Immunoassays cross-react with structurally related steroids and are unreliable for pregnenolone, so LC-MS/MS results are not interchangeable with immunoassay results and serial monitoring must use the same method.
High-dose biotin can interfere with streptavidin-biotin immunoassays but does not affect LC-MS/MS, so this test is not subject to biotin interference — an advantage of the mass-spectrometry method.
Pregnenolone varies with sex, age, pregnancy, and cycle phase, so results must be interpreted against appropriate reference intervals rather than a single adult range.
What do Pregnenolone results mean?
Elevated
An elevated pregnenolone may reflect supplementation, ACTH-driven adrenal stimulation, or certain steroidogenic enzyme blocks that cause upstream precursor accumulation. It is interpreted within the full steroid pathway rather than in isolation, and supplementation should be excluded first.
Normal
A normal pregnenolone alone neither confirms nor excludes a steroidogenic disorder. It is interpreted in the context of the full precursor-and-product panel and the clinical picture, since pathway abnormalities are defined by the pattern of steroids rather than any single value.
Reduced
A low pregnenolone can reflect adrenal insufficiency, suppression by exogenous glucocorticoids, or a proximal steroidogenic defect (for example affecting StAR or CYP11A1), and is interpreted alongside ACTH, cortisol, and downstream steroids to localise the level of the problem.
Note: Pregnenolone is a low-concentration steroid best measured by LC-MS/MS; immunoassay results are unreliable and not interchangeable. It is rarely diagnostic on its own and is read within a steroid-pathway panel. Functional 'adrenal precursor' interpretations are not well established, and reference intervals are age-, sex-, and cycle-dependent and assay-specific.
Frequently asked questions
It measures serum pregnenolone, the master steroid precursor and first product of steroidogenesis from cholesterol. Pregnenolone is upstream of all steroid hormones and is used mainly to characterise the steroidogenic pathway.
How to access the Pregnenolone test
The Pregnenolone reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: July 16, 2026
Last reviewed: July 16, 2026
- Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. (2011)
- Speiser PW, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. (2018)
- Bornstein SR, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. (2016)
- Kushnir MM, et al. Liquid chromatography-tandem mass spectrometry applications in endocrinology. Clin Biochem. (2011)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
adrenal stress
DHEA-S
The DHEA-S (Dehydroepiandrosterone Sulfate) Serum test measures the sulfated storage form of the primary adrenal androgen prohormone — the most analytically stable adrenal androgen marker with minimal diurnal variation, suitable for collection at any time of day.
female hormones
17-OHP
The 17-hydroxyprogesterone test measures serum 17-OHP, a steroid intermediate that accumulates in 21-hydroxylase deficiency, the most common form of congenital adrenal hyperplasia. It is the first-line biochemical test for diagnosing classic and non-classic CAH, distinguishing it from other causes of virilisation and hyperandrogenism, with borderline values prompting cosyntropin stimulation for…
adrenal stress
Cortisol
The serum Cortisol test measures the principal glucocorticoid to assess hypothalamic-pituitary-adrenal axis function. Because cortisol follows a circadian rhythm, collection time is integral to interpretation, with morning sampling standard for adrenal insufficiency screening.